Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Olon S P A has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This matter is handled by 1 distinct examiner and a distinct art unit. This concentrated prosecution profile suggests that the company is currently focusing its intellectual property efforts on a specific pharmaceutical development.
JERICA KATLYNN WILSON is the busiest examiner for the company, managing the 1 pending office action. This assignment means that the primary point of contact for the company's current prosecution is the identified examiner. For the company, the resolution of the pending office action depends on the specific interpretation of the identified examiner. Practitioners should focus on building a clear understanding of this examiner's perspective, as the success of the company's current patenting activity in the Biotechnology & Pharmaceuticals sector is tied to the outcome of this pending matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WILSON, JERICA KATLYNN | 1 | 60.5% | +39.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18862437 | PURIFICATION PROCESSES OF RIFAMPICIN FROM NITROSAMINES | WILSON, JERICA KATLYNN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18862437 | PURIFICATION PROCESSES OF RIFAMPICIN FROM NITROSAMINES | WILSON, JERICA KATLYNN | — |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18862437 | PURIFICATION PROCESSES OF RIFAMPICIN FROM NITROSAMINES | WILSON, JERICA KATLYNN | 1621 | §102§112 | Non-Final OA | — | Pending | Nov 01, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialOlon S P A has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jerica Katlynn Wilson has the most, with 1 of Olon S P A's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.